ZCG
WST icon

Zesiger Capital Group’s West Pharmaceutical WST Stock Holding History

Zesiger Capital Group’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		$3.81M Sell
71,575
-148,944
-68% -$7.45M 6.43% 8
2014
Q3 		$9.87M Buy
+220,519
New +$9.37M 4.15% 13

Other funds holding WST

Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
KI
Kalmar Investments Greenville, Delaware $443M AUM 23.5% 1-Year Est. Return
RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Zesiger Capital Group's WST Position: Q4 2014 in Review

Zesiger Capital Group reduced its West Pharmaceutical (WST) stake by 68% in Q4 2014, selling an estimated $7.45M and leaving 71,575 shares worth $3.81M. The position accounts for 6.43% of the portfolio, ranked #8.

Zesiger Capital Group first reported a position in WST in Q3 2014 and has held it in 2 quarters since. The position peaked at $9.87M in Q3 2014. 225 funds tracked by Wall St. Rank hold WST as of Q4 2014.

  • Zesiger Capital Group held 71,575 shares of West Pharmaceutical worth $3.81M as of Q4 2014.
  • Zesiger Capital Group sold 148,944 West Pharmaceutical shares in Q4 2014, an estimated $7.45M.
  • West Pharmaceutical made up 6.43% of Zesiger Capital Group's portfolio in Q4 2014, its #8 holding.
  • Zesiger Capital Group first reported a position in West Pharmaceutical in Q3 2014 and has held it in 2 quarters since.
  • Zesiger Capital Group's West Pharmaceutical position peaked at $9.87M in Q3 2014.
  • 225 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2014.

Based on Zesiger Capital Group's 13F filing for Q4 2014, filed 13 Feb 2015.